Company Filing History:
2 out of 5,101 
2 out of 132 
2 out of 1,746 
Years Active: 2015-2021
Title: Innovations of Katy Billot: A Pioneer in Cancer Research
Introduction
Katy Billot, an accomplished inventor based in Bourg la Reine, France, has made significant contributions to the field of cancer research through her innovative inventions. With a total of three patents to her name, Katy continues to impact the medical community, particularly in understanding and monitoring cancer and inflammatory reactions.
Latest Patents
One of her latest patents focuses on the "Method for monitoring cancer and/or inflammatory reaction based on RelB phosphorylation." This invention demonstrates that the RelB subunit of NF-κB plays a crucial role in promoting cell migration. Katy and her team identified that the pro-migratory activity is mediated through the activation of the NF-κB pathway, particularly by the phosphorylation of RelB at serine 472. This invention not only proposes a method to monitor the NF-κB pathway but also introduces methods and kits designed for prognosing the evolution of diseases involving cell migration based on the detection of RelB-S472 phosphorylation.
Career Highlights
Katy Billot has worked for esteemed organizations, including the Centre National de la Recherche Scientifique and Université Paris Descartes. Her career path reflects a deep commitment to research and innovation, allowing her to develop groundbreaking methods that advance scientific understanding in her field.
Collaborations
Throughout her career, Katy has collaborated with notable colleagues such as Veronique Baud and Angelita Rebollo Garcia. These partnerships have further enriched her research, leading to the successful development of her patented inventions.
Conclusion
Katy Billot's innovative spirit and dedication to cancer research exemplify her role as a leader in her field. With her latest patents, she is poised to make significant contributions to medical science, particularly in improving methodologies for monitoring diseases linked to cell migration. Her work will undoubtedly pave the way for future research and treatments in cancer and inflammatory conditions.